Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA

    April 2022 in “ Dermatology and therapy ”
    Arash Mostaghimi, Jason Xenakis, Aster Meche … Vanja Sikirica
    Studysummary This study reports that patients with alopecia areata in the US incur significantly higher healthcare utilization and expenses, primarily driven by ambulatory and pharmacy costs, compared to matched controls.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 16

    1. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims Advances in Therapy · 2021
    2. A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States Clinical Cosmetic and Investigational Dermatology · 2020
    3. The Psychosocial Burden of Alopecia Areata and Androgenetic Alopecia: A Cross-Sectional Multicentre Study Among Dermatological Outpatients in 13 European Countries Journal of the European Academy of Dermatology and Venereology · 2019
    4. Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis Journal of The American Academy of Dermatology · 2018
    5. Cancer Risk by the Subtype of Alopecia Scientific Reports · 2018
    6. Cancer Risk in Patients with Alopecia Areata: A Nationwide Population-Based Matched Cohort Study Cancer Medicine · 2018
    7. Alopecia Areata Is Associated With Increased Expression of Heart Disease Biomarker Cardiac Troponin I Acta dermato-venereologica · 2018
    8. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    9. Comorbidities in Patients with Alopecia Areata Journal of the American Academy of Dermatology · 2017
    10. Cardiovascular Risk in Patients with Alopecia Areata: A Propensity-Matched Retrospective Analysis Journal of the American Academy of Dermatology · 2016
    11. Alopecia Secondary to Anti-Tumor Necrosis Factor-Alpha Therapy Anais Brasileiros de Dermatologia · 2015
    12. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib EBioMedicine · 2015
    13. Global Burden of Skin Disease as Reflected in Cochrane Database of Systematic Reviews JAMA Dermatology · 2014
    14. Current Treatment of Alopecia Areata ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2013
    15. Overview of Alopecia Areata ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2013
    16. The Genetics of Alopecia Areata: What's New and How Will It Help Our Patients? Dermatologic therapy · 2011